GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » FCF Yield %

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) FCF Yield % : 1.47 (As of Dec. 11, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Shenzhenlubris Pharmaceuticals Co's Trailing 12-Month Free Cash Flow is ¥561 Mil, and Market Cap is ¥38,141 Mil. Therefore, Shenzhenlubris Pharmaceuticals Co's FCF Yield % for today is 1.47%.

The historical rank and industry rank for Shenzhenlubris Pharmaceuticals Co's FCF Yield % or its related term are showing as below:

SZSE:002294' s FCF Yield % Range Over the Past 10 Years
Min: 0.11   Med: 2.69   Max: 5.96
Current: 1.47


During the past 13 years, the highest FCF Yield % of Shenzhenlubris Pharmaceuticals Co was 5.96%. The lowest was 0.11%. And the median was 2.69%.

SZSE:002294's FCF Yield % is ranked better than
68.97% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: -2.06 vs SZSE:002294: 1.47

Shenzhenlubris Pharmaceuticals Co's FCF Margin % for the quarter that ended in Sep. 2024 was 15.39%.


Shenzhenlubris Pharmaceuticals Co FCF Yield % Historical Data

The historical data trend for Shenzhenlubris Pharmaceuticals Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhenlubris Pharmaceuticals Co FCF Yield % Chart

Shenzhenlubris Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.03 2.47 2.31 1.02 0.46

Shenzhenlubris Pharmaceuticals Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.50 1.67 1.43 1.97 1.53

Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's FCF Yield %

For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhenlubris Pharmaceuticals Co's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's FCF Yield % falls into.



Shenzhenlubris Pharmaceuticals Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Shenzhenlubris Pharmaceuticals Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=168.444 / 36410.0212
=0.46%

Shenzhenlubris Pharmaceuticals Co's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=147.492 * 4 / 38639.6612
=1.53%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhenlubris Pharmaceuticals Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Shenzhenlubris Pharmaceuticals Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhenlubris Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6009 Shennan Road, 37th Floor, Main Building, Chegongmiao Lvjing Plaza, Futian District, Guangdong, Shenzhen, CHN, 518040
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.
Executives
Yan Jie Directors, executives
Yang Jian Feng Secretary, Director
Zhao Song Ping Executives
Liu Jun Executives
Li Ai Zhen Supervisors
Chen Ping Executives
Ye Cheng Hai Director
Lu Feng Executives, directors
Chen Qiong Xing Supervisors
Li Ying Hui Supervisors
Pan Ling Man Independent director
Zhang Zhong Xing Executives

Shenzhenlubris Pharmaceuticals Co Headlines

No Headlines